News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
220,566 Results
Type
Article (22021)
Company Profile (129)
Press Release (198416)
Multimedia
Podcasts (39)
Webinars (4)
Section
Business (56423)
Career Advice (256)
Deals (8510)
Drug Delivery (37)
Drug Development (44009)
Employer Resources (25)
FDA (4929)
Job Trends (4721)
News (109990)
Policy (8145)
Tag
Academia (1290)
Academic (1)
Accelerated approval (5)
Adcomms (14)
Allergies (25)
Alliances (17348)
ALS (55)
Alzheimer's disease (555)
Antibody-drug conjugate (ADC) (123)
Approvals (4946)
Artificial intelligence (81)
Autoimmune disease (18)
Automation (7)
Bankruptcy (50)
Best Places to Work (4125)
BIOSECURE Act (7)
Biosimilars (42)
Biotechnology (103)
Bladder cancer (50)
Brain cancer (19)
Breast cancer (186)
Cancer (1828)
Cardiovascular disease (46)
Career advice (213)
Career pathing (5)
CAR-T (164)
Cell therapy (468)
Cervical cancer (15)
Clinical research (34458)
Collaboration (451)
Compensation (181)
Complete response letters (9)
COVID-19 (1139)
CRISPR (41)
C-suite (114)
Cystic fibrosis (64)
Data (1304)
Denatured (12)
Depression (7)
Diabetes (87)
Diagnostics (1963)
Digital health (3)
Diversity, equity & inclusion (5)
Drug discovery (65)
Drug pricing (22)
Drug shortages (2)
Duchenne muscular dystrophy (54)
Earnings (19589)
Editorial (10)
Employer branding (3)
Employer resources (23)
Events (35177)
Executive appointments (281)
FDA (5474)
Friedreich's ataxia (4)
Frontotemporal dementia (4)
Funding (329)
Gene editing (91)
Generative AI (6)
Gene therapy (259)
GLP-1 (216)
Government (1086)
Grass and pollen (1)
Guidances (20)
Healthcare (5728)
Huntington's disease (9)
IgA nephropathy (15)
Immunology and inflammation (82)
Indications (17)
Infectious disease (1192)
Inflammatory bowel disease (63)
Inflation Reduction Act (7)
Influenza (17)
Intellectual property (48)
Interviews (46)
IPO (4422)
IRA (10)
Job creations (815)
Job search strategy (184)
Kidney cancer (11)
Labor market (7)
Layoffs (181)
Leadership (2)
Legal (979)
Liver cancer (56)
Lung cancer (324)
Lymphoma (153)
Machine learning (3)
Management (9)
Manufacturing (138)
MASH (19)
Medical device (1385)
Medtech (1387)
Mergers & acquisitions (4355)
Metabolic disorders (190)
Multiple sclerosis (57)
NASH (3)
Neurodegenerative disease (44)
Neuropsychiatric disorders (5)
Neuroscience (803)
NextGen: Class of 2025 (1633)
Non-profit (998)
Now hiring (10)
Obesity (81)
Opinion (77)
Ovarian cancer (65)
Pain (22)
Pancreatic cancer (49)
Parkinson's disease (62)
Partnered (8)
Patents (97)
Patient recruitment (60)
Peanut (14)
People (16923)
Pharmaceutical (18)
Phase I (13226)
Phase II (15761)
Phase III (9984)
Pipeline (618)
Policy (33)
Postmarket research (746)
Preclinical (6100)
Press Release (56)
Prostate cancer (65)
Psychedelics (10)
Radiopharmaceuticals (125)
Rare diseases (248)
Real estate (1494)
Recruiting (10)
Regulatory (7041)
Reports (18)
Research institute (1271)
Resumes & cover letters (38)
Rett syndrome (1)
RNA editing (4)
RSV (14)
Schizophrenia (24)
Series A (70)
Series B (32)
Service/supplier (4)
Sickle cell disease (58)
Special edition (4)
Spinal muscular atrophy (97)
Sponsored (12)
Startups (1455)
State (1)
Stomach cancer (12)
Supply chain (19)
Tariffs (3)
The Weekly (26)
Vaccines (282)
Venture capitalists (20)
Weight loss (41)
Women's health (10)
Worklife (3)
Date
Today (65)
Last 7 days (443)
Last 30 days (1227)
Last 365 days (14693)
2025 (4727)
2024 (15589)
2023 (17301)
2022 (21320)
2021 (22174)
2020 (18892)
2019 (13002)
2018 (9881)
2017 (11086)
2016 (10031)
2015 (11976)
2014 (8102)
2013 (6904)
2012 (7130)
2011 (7006)
2010 (6134)
Location
Africa (160)
Alabama (15)
Alaska (3)
Arizona (45)
Arkansas (2)
Asia (15045)
Australia (2964)
California (3041)
Canada (669)
China (312)
Colorado (78)
Connecticut (77)
Delaware (78)
Europe (31981)
Florida (263)
Georgia (54)
Idaho (21)
Illinois (147)
India (7)
Indiana (72)
Iowa (4)
Japan (82)
Kansas (25)
Kentucky (6)
Maine (41)
Maryland (340)
Massachusetts (2275)
Michigan (43)
Minnesota (99)
Missouri (18)
Montana (6)
Nebraska (6)
Nevada (21)
New Hampshire (7)
New Jersey (749)
New Mexico (15)
New York (750)
North Carolina (377)
North Dakota (8)
Northern California (1344)
Ohio (87)
Oklahoma (6)
Oregon (11)
Pennsylvania (573)
Puerto Rico (3)
Rhode Island (16)
South America (225)
South Carolina (1)
Southern California (1197)
Tennessee (10)
Texas (455)
United States (9997)
Utah (54)
Virginia (53)
Washington D.C. (11)
Washington State (346)
Wisconsin (16)
220,566 Results for "celling biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
April 30, 2025
·
8 min read
Press Releases
Solid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual Meeting
April 30, 2025
·
7 min read
Press Releases
Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing
February 19, 2025
·
2 min read
Press Releases
March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First-in-Class CD5 CAR-T Cell Therapy for T-Cell Lymphoma
April 23, 2025
·
4 min read
Press Releases
Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products
March 4, 2025
·
2 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Scale Biosciences Launches Five Single Cell Profiling Products, Unlocking Single Cell RNA Studies at Any Scale
February 24, 2025
·
4 min read
Press Releases
Precision BioSciences Announces Multiple Presentations for In Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 1, 2025
·
9 min read
Press Releases
Hope Biosciences Launches Pioneering Stem Cell Trial for Pediatric Juvenile Idiopathic Arthritis
March 5, 2025
·
2 min read
Press Releases
AP Biosciences Presents Preclinical Data on p95HER/CD137 T-Cell Engager at American Association of Cancer Research Annual Meeting
April 30, 2025
·
3 min read
1 of 22,057
Next
